1. Influence of Disease Severity and Gender on HLA-C Methylation in COVID-19 Patients
- Author
-
Mohsen Sharif-zak, Mojtaba Abbasi-Jorjandi, Gholamreza Asadikaram, Zohreh-al-Sadat Ghoreshi, Mitra Rezazadeh-Jabalbarzi, and Hamidreza Rashidinejad
- Subjects
General Mathematics ,General Physics and Astronomy ,General Earth and Planetary Sciences ,General Chemistry ,General Agricultural and Biological Sciences - Abstract
In the pathophysiology of COVID-19, immunomodulatory factors play a vital role. Viruses have epigenetic effects on various genes, particularly methylation. Explaining the changes in immunological factor methylation levels during viral infections requires substantial consideration. HLA-C is a crucial determinant of immune function and NK cell activity and is primarily implicated in viral infections. This research focused on studying HLA-C methylation in COVID-19 patients with different severity. Peripheral blood samples were collected from 470 patients (235 men and 235 women) with RT-qPCR-confirmed COVID-19 test and classified into moderate, severe, and critical groups based on WHO criteria. Also, one hundred (50 men and 50 women) healthy subjects were selected as the control group. Peripheral blood mononuclear cells were used for DNA extraction, and the methylation-specific PCR (MSP) method and gel electrophoresis were used to determine the methylation status of the HLA-C. Significant statistical differences in HLA-C methylation were observed among cases and controls and various stages of the disease. HLA-C methylation in men and women has decreased in all stages (
- Published
- 2022
- Full Text
- View/download PDF